Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,685 | -63,193 | -34,065 | -134,309 | -98,143 |
| Depreciation Amortization | -240 | 17 | 255 | 1,904 | 1,075 |
| Income taxes - deferred | N/A | N/A | N/A | -368 | N/A |
| Accounts receivable | -11,962 | 382 | 358 | -359 | -2 |
| Accounts payable and accrued liabilities | -701 | 3,988 | 226 | 1,967 | 366 |
| Other Working Capital | -7,636 | -6,364 | 582 | 909 | -1,646 |
| Other Operating Activity | 22,177 | 1,941 | 2,303 | 9,823 | 8,309 |
| Operating Cash Flow | $-99,047 | $-63,229 | $-30,341 | $-120,433 | $-90,041 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -63,659 | -97,354 | -67,775 | 114,314 | 76,900 |
| PPE Investments | -152 | -109 | -108 | -984 | -737 |
| Investing Cash Flow | $-63,811 | $-97,463 | $-67,883 | $113,330 | $76,163 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -129 | -129 | -110 | -620 | -460 |
| Common Stock Issued | 2,602 | 2,063 | 1,959 | 156,880 | 156,237 |
| Other Financing Activity | 0 | 0 | 0 | -388 | 0 |
| Financing Cash Flow | $2,473 | $1,934 | $1,849 | $155,872 | $155,777 |
| Beginning Cash Position | 227,126 | 227,126 | 227,126 | 78,357 | 78,357 |
| End Cash Position | 66,741 | 68,368 | 130,751 | 227,126 | 220,256 |
| Net Cash Flow | $-160,385 | $-158,758 | $-96,375 | $148,769 | $141,899 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,047 | -63,229 | -30,341 | -120,433 | -90,041 |
| Capital Expenditure | -152 | -109 | -108 | -984 | -737 |
| Free Cash Flow | -99,199 | -63,338 | -30,449 | -121,417 | -90,778 |